BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33929593)

  • 1. Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.
    Förster A; Brand F; Banan R; Hüneburg R; Weber CAM; Ewert W; Kronenberg J; Previti C; Elyan N; Beyer U; Martens H; Hong B; Bräsen JH; Erbersdobler A; Krauss JK; Stangel M; Samii A; Wolf S; Preller M; Aretz S; Wiese B; Hartmann C; Weber RG
    Acta Neuropathol; 2021 Jul; 142(1):191-210. PubMed ID: 33929593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
    Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
    J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma.
    Wang L; Zhang F; Wu PP; Jiang XC; Zheng L; Yu YY
    World J Gastroenterol; 2006 Jul; 12(26):4228-31. PubMed ID: 16830381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
    Garziera M; Canzonieri V; Cannizzaro R; Geremia S; Caggiari L; De Zorzi M; Maiero S; Orzes E; Perin T; Zanussi S; De Paoli P; De Re V
    PLoS One; 2013; 8(10):e77035. PubMed ID: 24204729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of E-cadherin gene in human neuroepithelial tumors.
    Motta FJ; Valera ET; Lucio-Eterovic AK; Queiroz RG; Neder L; Scrideli CA; Machado HR; Carlotti-Junior CG; Marie SK; Tone LG
    Genet Mol Res; 2008 Apr; 7(2):295-304. PubMed ID: 18551395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PATHOLOGICAL SIGNIFICANCE OF CDH1/E-CADHERIN GERMLINE SEQUENCE VARIANTS IN BREAST CANCER PATIENTS.
    Tabassum S; Munir F; Al Awadh AA; Anwar Z
    Exp Oncol; 2023 Oct; 45(2):170-179. PubMed ID: 37824775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer predisposition and germline CTNNA1 variants.
    Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
    Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
    Sarrió D; Moreno-Bueno G; Hardisson D; Sánchez-Estévez C; Guo M; Herman JG; Gamallo C; Esteller M; Palacios J
    Int J Cancer; 2003 Aug; 106(2):208-15. PubMed ID: 12800196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
    Richards FM; McKee SA; Rajpar MH; Cole TR; Evans DG; Jankowski JA; McKeown C; Sanders DS; Maher ER
    Hum Mol Genet; 1999 Apr; 8(4):607-10. PubMed ID: 10072428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas.
    Qian ZR; Sano T; Yoshimoto K; Asa SL; Yamada S; Mizusawa N; Kudo E
    Mod Pathol; 2007 Dec; 20(12):1269-77. PubMed ID: 17873891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview on new progress of hereditary diffuse gastric cancer with
    Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
    Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of E-Cadherin and
    García-Ruvalcaba A; Vázquez-Ibarra KC; Magaña-Torres MT; Rizo de-la-Torre LDC; Meléndez-Aranda L; López-Armas G; Cruz-Ramos JA; Peregrina-Sandoval J; Espinoza-Jiménez E; Rosales-Gradilla ME; Sánchez-López JY
    Rev Invest Clin; 2023 Feb; 75(1):037-044. PubMed ID: 36652613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants in members of the cadherin-catenin complex, CDH1 and CTNND1, cause blepharocheilodontic syndrome.
    Kievit A; Tessadori F; Douben H; Jordens I; Maurice M; Hoogeboom J; Hennekam R; Nampoothiri S; Kayserili H; Castori M; Whiteford M; Motter C; Melver C; Cunningham M; Hing A; Kokitsu-Nakata NM; Vendramini-Pittoli S; Richieri-Costa A; Baas AF; Breugem CC; Duran K; Massink M; Derksen PWB; van IJcken WFJ; van Unen L; Santos-Simarro F; Lapunzina P; Gil-da Silva Lopes VL; Lustosa-Mendes E; Krall M; Slavotinek A; Martinez-Glez V; Bakkers J; van Gassen KLI; de Klein A; van den Boogaard MH; van Haaften G
    Eur J Hum Genet; 2018 Feb; 26(2):210-219. PubMed ID: 29348693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition and nuclear β-catenin induced by conditional intestinal disruption of Cdh1 with Apc is E-cadherin EC1 domain dependent.
    Matheson J; Bühnemann C; Carter EJ; Barnes D; Hoppe HJ; Hughes J; Cobbold S; Harper J; Morreau H; Surakhy M; Hassan AB
    Oncotarget; 2016 Oct; 7(43):69883-69902. PubMed ID: 27566565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
    Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D
    Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.
    Corso G; Marrelli D; Pascale V; Vindigni C; Roviello F
    BMC Cancer; 2012 Jan; 12():8. PubMed ID: 22225527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.
    Jakubowska A; Lawniczak M; Wojnarska B; Cybulski C; Huzarski T; Byrski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Starzyńska T; Lubiński J
    Fam Cancer; 2010 Dec; 9(4):605-8. PubMed ID: 20842455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
    BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.